OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rational design of new multitarget histamine H3 receptor ligands as potential candidates for treatment of Alzheimer’s disease
Dorota Łażewska, Marek Bajda, Maria Kaleta, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112743-112743
Closed Access | Times Cited: 24
Dorota Łażewska, Marek Bajda, Maria Kaleta, et al.
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112743-112743
Closed Access | Times Cited: 24
Showing 24 citing articles:
Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease
Donia E. Hafez, Mariam Dubiel, Gabriella La Spada, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 29
Donia E. Hafez, Mariam Dubiel, Gabriella La Spada, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 29
Dual-Target Inhibitors Based on Acetylcholinesterase: Novel Agents for Alzheimer's Disease
Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116810-116810
Closed Access | Times Cited: 9
Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116810-116810
Closed Access | Times Cited: 9
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
Da-Jiang Zou, Renzheng Liu, Yangjing Lv, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 22
Da-Jiang Zou, Renzheng Liu, Yangjing Lv, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 22
An Expanded Narrative Review of Neurotransmitters on Alzheimer’s Disease: The Role of Therapeutic Interventions on Neurotransmission
Enes Akyüz, Alina Arulsamy, Feyza Şule Aslan, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 5
Enes Akyüz, Alina Arulsamy, Feyza Şule Aslan, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 5
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties
Katarzyna Szczepańska, Sabina Podlewska, Maria Dichiara, et al.
ACS Chemical Neuroscience (2021) Vol. 13, Iss. 1, pp. 1-15
Open Access | Times Cited: 31
Katarzyna Szczepańska, Sabina Podlewska, Maria Dichiara, et al.
ACS Chemical Neuroscience (2021) Vol. 13, Iss. 1, pp. 1-15
Open Access | Times Cited: 31
Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery
Pakhuri Mehta, Przemysław Miszta, Sławomir Filipek
Molecules (2021) Vol. 26, Iss. 6, pp. 1778-1778
Open Access | Times Cited: 28
Pakhuri Mehta, Przemysław Miszta, Sławomir Filipek
Molecules (2021) Vol. 26, Iss. 6, pp. 1778-1778
Open Access | Times Cited: 28
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain
Katarzyna Szczepańska, Tadeusz Karcz, Maria Dichiara, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9658-9683
Open Access | Times Cited: 11
Katarzyna Szczepańska, Tadeusz Karcz, Maria Dichiara, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9658-9683
Open Access | Times Cited: 11
Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease
Paula Zaręba, Kamil Łątka, Gabriela Mazur, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115832-115832
Open Access | Times Cited: 9
Paula Zaręba, Kamil Łątka, Gabriela Mazur, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115832-115832
Open Access | Times Cited: 9
Nature as a source and inspiration for human monoamine oxidase B (hMAO-B) inhibition: A review of the recent advances in chemical modification of natural compounds
Francesco Melfi, Simone Carradori, Andrea Angeli, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 8, pp. 851-879
Closed Access | Times Cited: 8
Francesco Melfi, Simone Carradori, Andrea Angeli, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 8, pp. 851-879
Closed Access | Times Cited: 8
Discovery of novel 3-butyl-6-benzyloxyphthalide Mannich base derivatives as multifunctional agents against Alzheimer's disease
Zhuoling Liu, Yichun Shi, Xiaoyu Zhang, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 58, pp. 116660-116660
Closed Access | Times Cited: 13
Zhuoling Liu, Yichun Shi, Xiaoyu Zhang, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 58, pp. 116660-116660
Closed Access | Times Cited: 13
Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer’s disease
Justyna Godyń, Paula Zaręba, Dorota Łażewska, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105129-105129
Open Access | Times Cited: 15
Justyna Godyń, Paula Zaręba, Dorota Łażewska, et al.
Bioorganic Chemistry (2021) Vol. 114, pp. 105129-105129
Open Access | Times Cited: 15
Histamine H3 receptor and cholinesterases as synergistic targets for cognitive decline: Strategies to the rational design of multitarget ligands
Flávia B. Lopes, Cecília M. S. Q. Aranha, João Paulo S. Fernandes
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 2, pp. 212-225
Closed Access | Times Cited: 14
Flávia B. Lopes, Cecília M. S. Q. Aranha, João Paulo S. Fernandes
Chemical Biology & Drug Design (2021) Vol. 98, Iss. 2, pp. 212-225
Closed Access | Times Cited: 14
Multitargeting Histamine H3 Receptor Ligands among Acetyl- and Propionyl-Phenoxyalkyl Derivatives
Dorota Łażewska, Maria Kaleta, Paula Zaręba, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2349-2349
Open Access | Times Cited: 5
Dorota Łażewska, Maria Kaleta, Paula Zaręba, et al.
Molecules (2023) Vol. 28, Iss. 5, pp. 2349-2349
Open Access | Times Cited: 5
Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 1
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 1
Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides
Michał Abram, Marcin Jakubiec, Anna Rapacz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13092-13092
Open Access | Times Cited: 8
Michał Abram, Marcin Jakubiec, Anna Rapacz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13092-13092
Open Access | Times Cited: 8
Benzophenone Derivatives with Histamine H3 Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer’s Disease
Justyna Godyń, Paula Zaręba, Dorota Stary, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 238-238
Open Access | Times Cited: 5
Justyna Godyń, Paula Zaręba, Dorota Stary, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 238-238
Open Access | Times Cited: 5
Dual Targeting Ligands—Histamine H3 Receptor Ligands with Monoamine Oxidase B Inhibitory Activity—In Vitro and In Vivo Evaluation
Dorota Łażewska, Agata Siwek, Agnieszka Olejarz‐Maciej, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2187-2187
Open Access | Times Cited: 4
Dorota Łażewska, Agata Siwek, Agnieszka Olejarz‐Maciej, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2187-2187
Open Access | Times Cited: 4
Biphenylalkoxyamine Derivatives–Histamine H3 Receptor Ligands with Butyrylcholinesterase Inhibitory Activity
Dorota Łażewska, Paula Zaręba, Justyna Godyń, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3580-3580
Open Access | Times Cited: 5
Dorota Łażewska, Paula Zaręba, Justyna Godyń, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3580-3580
Open Access | Times Cited: 5
Clinical Biomarkers and Novel Drug Targets to Cut Gordian Knots of Alzheimer's Disease
Reyaz Hassan Mir, Mubashir Hussain Masoodi, Abdul Jalil Shah, et al.
Current Molecular Pharmacology (2022) Vol. 16, Iss. 3, pp. 254-279
Closed Access | Times Cited: 3
Reyaz Hassan Mir, Mubashir Hussain Masoodi, Abdul Jalil Shah, et al.
Current Molecular Pharmacology (2022) Vol. 16, Iss. 3, pp. 254-279
Closed Access | Times Cited: 3
Recent Advances in the Search for Effective Anti-Alzheimer’s Drugs
Martyna Ogos, Dorota Stary, Marek Bajda
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 157-157
Open Access
Martyna Ogos, Dorota Stary, Marek Bajda
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 157-157
Open Access
Histamine H 3 receptor antagonists/inverse agonists: a patent review (October 2017- December 2023) documenting progress
Dorota Łażewska, Katarzyna Kieć‐Kononowicz
Expert Opinion on Therapeutic Patents (2024), pp. 1-25
Open Access
Dorota Łażewska, Katarzyna Kieć‐Kononowicz
Expert Opinion on Therapeutic Patents (2024), pp. 1-25
Open Access
Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease
Silvia Pérez‐Silanes, Eva Martišová, Esther Moreno, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 799-799
Open Access
Silvia Pérez‐Silanes, Eva Martišová, Esther Moreno, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 799-799
Open Access
First Report on Cationic Triphenylphosphonium Compounds as Mitochondriotropic H3R Ligands with Antioxidant Properties
Tobias Werner, Tito Añazco, Paula Osses-Mendoza, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1345-1345
Open Access
Tobias Werner, Tito Añazco, Paula Osses-Mendoza, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1345-1345
Open Access
Guanidine Derivative ADS1017, a Potent Histamine H3 Receptor Antagonist with Promising Analgesic Activity and Satisfactory Safety Profile
Tadeusz Karcz, Katarzyna Szczepańska, Szczepan Mogilski, et al.
ACS Chemical Neuroscience (2024)
Closed Access
Tadeusz Karcz, Katarzyna Szczepańska, Szczepan Mogilski, et al.
ACS Chemical Neuroscience (2024)
Closed Access
